{"name": "Axerion Therapeutics", "permalink": "axerion-therapeutics", "crunchbase_url": "http://www.crunchbase.com/company/axerion-therapeutics", "homepage_url": "http://www.axeriontherapeutics.com/", "blog_url": "", "blog_feed_url": "", "twitter_username": "", "category_code": "biotech", "number_of_employees": null, "founded_year": null, "founded_month": null, "founded_day": null, "deadpooled_year": null, "deadpooled_month": null, "deadpooled_day": null, "deadpooled_url": null, "tag_list": "", "alias_list": "", "email_address": "info@AxerionTherapeutics.com", "phone_number": "203-492-0550", "description": "", "created_at": "Wed Jul 07 02:14:25 UTC 2010", "updated_at": "Fri Oct 14 04:45:59 UTC 2011", "overview": "\u003Cp\u003EAxerion Therapeutics, Inc. is a private Connecticut-based biotechnology company focused on developing innovative therapeutics for neurological diseases and injuries with significant unmet medical need, including Alzheimer\u00e2\u20ac\u2122s disease and spinal cord injury.\u003C/p\u003E\n\n\u003Cp\u003EAxerion was established in New Haven to develop and commercialize intellectual property licensed from Dr. Stephen Strittmatter\u00e2\u20ac\u2122s laboratory at Yale University. Axerion\u00e2\u20ac\u2122s proprietary technology platforms include blockers of \u00c3\u0178-amyloid (A\u00c3\u0178) oligomers binding to Prion Proteins (PrP) on the cell surface of neurons as a novel therapeutic target for Alzheimer\u00e2\u20ac\u2122s disease and Nogo Receptor decoy protein for recovery of neurological function in spinal cord injury and other neurological diseases. \u003C/p\u003E", "image":  {"available_sizes":    [[[150,       28],      "assets/images/resized/0009/2594/92594v1-max-150x150.jpg"],     [[219,       42],      "assets/images/resized/0009/2594/92594v1-max-250x250.jpg"],     [[219,       42],      "assets/images/resized/0009/2594/92594v1-max-450x450.jpg"]],   "attribution": null}, "products":  [], "relationships":  [{"is_past": false,    "title": "President and CEO",    "person":     {"first_name": "Sylvia",      "last_name": "McBrinn",      "permalink": "sylvia-mcbrinn"}}], "competitions":  [], "providerships":  [], "total_money_raised": "$1.15M", "funding_rounds":  [{"round_code": "seed",    "source_url": "http://www.ctinnovations.com/news/436.php",    "source_description": "Connecticut Innovations Makes $750,000 Investment in Axerion Therapeutics, Inc.",    "raised_amount": 750000.0,    "raised_currency_code": "USD",    "funded_year": 2010,    "funded_month": 4,    "funded_day": 5,    "investments":     [{"company": null,       "financial_org":        {"name": "Connecticut Innovations",         "permalink": "connecticut-innovations"},       "person": null}]},   {"round_code": "unattributed",    "source_url": "http://www.masshightech.com/stories/2011/10/10/daily49-Conn-therapeutics-startup-Axerion-scores-more-CI-investments.html",    "source_description": "Conn. therapeutics startup Axerion scores more CI investments",    "raised_amount": 400000.0,    "raised_currency_code": "USD",    "funded_year": 2011,    "funded_month": 10,    "funded_day": 13,    "investments":     [{"company": null,       "financial_org":        {"name": "Connecticut Innovations",         "permalink": "connecticut-innovations"},       "person": null}]}], "investments":  [], "acquisition": null, "acquisitions":  [], "offices":  [{"description": "",    "address1": "555 Long Wharf Drive",    "address2": "11th Floor",    "zip_code": "06511",    "city": "New Haven",    "state_code": "CT",    "country_code": "USA",    "latitude": null,    "longitude": null}], "milestones":  [], "ipo": null, "video_embeds":  [], "screenshots":  [], "external_links":  []}